Fu, J. & Wu, H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu. Rev. Immunol. 41, 301–316 (2023).
de Carvalho Ribeiro, M. & Szabo, G. Role of the inflammasome in liver disease. Annu. Rev. Pathol. 17, 345–365 (2022).
Sharma, B. R. & Kanneganti, T. D. NLRP3 inflammasome in cancer and metabolic diseases. Nat. Immunol. 22, 550–559 (2021).
Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397–411 (2013).
de Sá, K. S. G. et al. Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection. Nat. Commun. 14, 1049 (2023).
Herrmann, B. I., Grayczyk, J. P. & Brodsky, I. E. Collab or cancel? Bacterial influencers of inflammasome signaling. Annu. Rev. Microbiol. 77, 451–477 (2023).
Gu, W., Zeng, Q., Wang, X., Jasem, H. & Ma, L. Acute lung injury and the NLRP3 inflammasome. J. Inflamm. Res. 17, 3801–3813 (2024).
Bauernfeind, F. G. et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 (2009).
Zheng, X., Wan, J. & Tan, G. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy. Front. Immunol. 14, 1151185 (2023).
Krieg, A. M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549 (1995).
Vollmer, J. & Krieg, A. M. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv. Drug Deliv. Rev. 61, 195–204 (2009).
Imaeda, A. B. et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305–314 (2009).
Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107 (2010).
Guo, R. et al. Targeting adenylate cyclase family: new concept of targeted cancer therapy. Front. Oncol. 12, 829212 (2022).
Steer, M. L. Adenyl cyclase. Ann. Surg. 182, 603–609 (1975).
Jiang, L. I., Collins, J., Davis, R., Fraser, I. D. & Sternweis, P. C. Regulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VII. J. Biol. Chem. 283, 23429–23439 (2008).
Sanchez-Collado, J., Lopez, J. J., Jardin, I., Salido, G. M. & Rosado, J. A. Cross-talk between the adenylyl cyclase/cAMP pathway and Ca2+ homeostasis. Rev. Physiol. Biochem. Pharmacol. 179, 73–116 (2021).
Devasani, K. & Yao, Y. Expression and functions of adenylyl cyclases in the CNS. Fluids Barriers CNS 19, 23 (2022).
Xia, Z., Choi, E. J., Wang, F., Blazynski, C. & Storm, D. R. Type I calmodulin-sensitive adenylyl cyclase is neural specific. J. Neurochem. 60, 305–311 (1993).
Dou, H. et al. Calcium influx activates adenylyl cyclase 8 for sustained insulin secretion in rat pancreatic beta cells. Diabetologia 58, 324–333 (2015).
Sadana, R. & Dessauer, C. W. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 17, 5–22 (2009).
Dessauer, C. W. et al. International Union of Basic and Clinical Pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases. Pharmacol. Rev. 69, 93–139 (2017).
Simonds, W. F. G protein regulation of adenylate cyclase. Trends Pharmacol. Sci. 20, 66–73 (1999).
Zhang, H. et al. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment. J. Hematol. Oncol. 17, 5 (2024).
Lee, G. S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123–127 (2012).
Abdul-Sater, A. A. et al. Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome. EMBO Rep. 14, 900–906 (2013).
Commichau, F. M., Gibhardt, J., Halbedel, S., Gundlach, J. & Stülke, J. A delicate connection: c-di-AMP affects cell integrity by controlling osmolyte transport. Trends Microbiol. 26, 175–185 (2018).
Kalia, D. et al. Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev. 42, 305–341 (2013).
Barker, J. R. et al. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. mBio 4, e00018-13 (2013).
Lam, K. C. et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 184, 5338–5356.e21 (2021).
Li, Y. et al. cGLRs are a diverse family of pattern recognition receptors in innate immunity. Cell. 186, 3261–3276.e20 (2023).
Novotná, B. et al. Enzymatic preparation of 2′-5′,3′-5′-cyclic dinucleotides, their binding properties to stimulator of interferon genes adaptor protein, and structure/activity correlations. J. Med. Chem. 62, 10676–10690 (2019).
Wu, J. & Chen, Z. J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461–488 (2014).
Blander, J. M. & Barbet, G. Exploiting vita-PAMPs in vaccines. Curr. Opin. Pharmacol. 41, 128–136 (2018).
Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477–489 (2019).
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L. & Falzoni, S. The P2X7 receptor in infection and inflammation. Immunity 47, 15–31 (2017).
Akbal, A. et al. How location and cellular signaling combine to activate the NLRP3 inflammasome. Cell. Mol. Immunol. 19, 1201–1214 (2022).
Schmacke, N. A. et al. IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. Immunity 55, 2271–2284 (2022).
Di, A. et al. The TWIK2 potassium efflux channel in macrophages mediates NLRP3 inflammasome-induced inflammation. Immunity 49, 56–65 (2018).
Clivio, P., Coantic-Castex, S. & Guillaume, D. (3′-5′)-Cyclic dinucleotides: synthetic strategies and biological potential. Chem. Rev. 113, 7354–7401 (2013).
Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS–STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501–521 (2020).
Millman, A., Melamed, S., Amitai, G. & Sorek, R. Diversity and classification of cyclic-oligonucleotide-based anti-phage signalling systems. Nat. Microbiol. 5, 1608–1615 (2020).
Liu, Q. et al. The TET3 inflammasome senses unique long HSV-1 proteins for virus particle budding from the nucleus. Cell. Mol. Immunol. 21, 1322–1334 (2024).
Qian, Y. et al. A VgrG2b fragment cleaved by caspase-11/4 promotes Pseudomonas aeruginosa infection through suppressing the NLRP3 inflammasome. eLife 13, RP99939 (2025).
Li, W. et al. Adipose triglyceride lipase suppresses noncanonical inflammasome by hydrolyzing LPS. Nat. Chem. Biol. 20, 1434–1442 (2024).
